PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Lung Cancer10.1016/s0169-5002(17)30116-22017103S3166: Outcomes of patients in the North Trent region with advanced non-small-cell lung cancer treated with maintenance pemetrexed following induction with platinum non-pemetrexed doublet chemotherapyR. Marshall, M. Kakoudaki, S.J. Danson, P.M. Fisher, M.Q. Hatton, C.E. Lee, T. Das, E. Bates, P. Woll, F. Taylorhttps://api.elsevier.com/content/article/PII:S0169500217301162?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0169500217301162?httpAccept=text/xml
The Korean Journal of Internal Medicine10.3904/kjim.2015.0422017325923-925Epiphora following chemotherapy with pemetrexed in patients with advanced non-small cell lung cancerYun Duk Jung, Sang Bin Lee, Yun Wha Jung, Jung Sub Song, In Sook Woohttp://kjim.org/upload/kjim-2015-042.pdf, http://kjim.org/journal/view.php?doi=10.3904/kjim.2015.042, http://www.kjim.org/upload/kjim-2015-042.pdf
Lung Cancer10.1016/0169-5002(94)90385-91994111-2144Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: Implications for the design of future non-small-cell lung cancer combined modality trialshttps://api.elsevier.com/content/article/PII:0169500294903859?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500294903859?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(91)91925-219917154Pathologic Complete Responses (PCR) in advanced Non-Small Cell Lung Cancer (NSCLC) following preoperative chemotherapyhttps://api.elsevier.com/content/article/PII:0169500291919252?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:0169500291919252?httpAccept=text/plain
Lung Cancer10.1016/j.lungcan.2010.09.0072010702230Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10]https://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500210004381?httpAccept=text/plain
Lung Cancer: Targets and Therapy10.2147/lctt.s73268201513Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancerSeigo Minami, Takashi Kijimahttps://www.dovepress.com/getfile.php?fileID=23477
Lung Cancer10.1016/s0169-5002(86)80466-4198621-2120Vindesine/cisplatin chemotherapy in patients with advanced non-small cell carcinoma of the lunghttps://api.elsevier.com/content/article/PII:S0169500286804664?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500286804664?httpAccept=text/plain
Lung Cancer10.1016/0169-5002(91)90382-g199174278Chemotherapy in advanced non-small cell lung cancerhttps://api.elsevier.com/content/article/PII:016950029190382G?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:016950029190382G?httpAccept=text/plain
Thoracic Cancer10.1111/j.1759-7714.2011.00096.x201232188-193Safety and efficacy of cetuximab combined with chemotherapy in Chinese patients with advanced non-small cell lung cancerXiaoyan Si, Li Zhanghttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1759-7714.2011.00096.x
Lung Cancer10.1016/j.lungcan.2013.09.0032013823511Vitamin supplementation in patients receiving pemetrexed for advanced non-small cell lung cancerFilippo de Marinis, Antonio Passaro, Stephen Clarkehttps://api.elsevier.com/content/article/PII:S0169500213004224?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213004224?httpAccept=text/plain